November 26, 2025 — Leads & Copy —
NeuralCloud Solutions Inc., a subsidiary of AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), has entered into a non-binding Commercial Agreement with Equimetrics to integrate NeuralCloud’s MaxYield™ and CardioYield™ platforms across Equimetrics’ V-PRO Clinical Monitoring and S-PRO Sports Performance product lines.
The agreement, signed on November 21, 2025, aims to expand NeuralCloud’s AI-enhanced ECG signal-processing technology into the veterinary health and elite equine performance markets.
The collaboration seeks to bring AI-driven ECG signal processing to the veterinary and equine health sector, enabling higher-fidelity, automated interpretation of electrocardiograms (ECG) to support both performance optimization and cardiac safety.
Equimetrics’ products rely on reliable, labeled ECG data for monitoring and diagnostics in horses. NeuralCloud’s MaxYield™ AI engine and CardioYield™ visualization layer together provide structured ECG outputs to enable faster throughput, reduced manual review, and improved diagnostic confidence.
Under the term sheet, NeuralCloud will provide API-level access to MaxYield™, its proprietary signal-enhancement and labeling engine. It will also give access to CardioYield™, a clinician-facing platform that generates beat-by-beat visualizations and reports from enhanced ECG data. The solution delivers denoised ECG waveforms, labeled PQRST intervals, and structured summary files, offering veterinarians and performance specialists a new standard in clarity and efficiency.
Esmat Naikyar, President of NeuralCloud and Chief Product Officer at AIML, said the collaboration marks an important expansion of the company’s AI signal-processing technology into veterinary and performance health.
Naikyar added that Equimetrics’ dedication to equine welfare and performance aligns perfectly with NeuralCloud’s mission to enable trustworthy, high-resolution physiological insights across both human and animal applications.
Equimetrics CEO Annemarie O’Brien said partnering with NeuralCloud allows the company to integrate cutting-edge AI directly into its V-PRO and S-PRO systems. O’Brien added that the ability to automatically label and interpret ECGs in real time represents a significant valuable addition for equine clinicians and trainers who require accurate cardiac insights.
AIML Executive Chairman and CEO Paul Duffy said the agreement highlights NeuralCloud’s growing commercial traction and the adaptability of its AI platform across medical and preclinical domains.
Duffy added that extending MaxYield’s capabilities to animal health not only validates the robustness of NeuralCloud’s technology but also opens new opportunities for global impact.
Equimetrics develops advanced digital monitoring solutions for veterinary and equine performance applications. Its V-PRO and S-PRO product lines combine sensor-based monitoring with intelligent analytics to protect equine health, optimize performance, and support data-driven care.
AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health.
Its proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights to support earlier diagnosis, personalized treatment, and more effective care.
AIML’s shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).
For detailed information, see AIML’s website or the Company’s filed documents at www.sedarplus.ca .
Blake Fallis (778) 405-0882
Paul Duffy, Executive Chairman and CEO
Source: AI/ML Innovations, Inc.
Source: AI/ML Innovations, Inc.
